首页 | 本学科首页   官方微博 | 高级检索  
     

北京地区医院急性脑卒中治疗与预防现况调查
引用本文:吴敌,王伊龙,郭乡平,马锐华,王春雪,王拥军.北京地区医院急性脑卒中治疗与预防现况调查[J].中华老年心脑血管病杂志,2005,7(6):394-397.
作者姓名:吴敌  王伊龙  郭乡平  马锐华  王春雪  王拥军
作者单位:1. 首都医科大学附属北京天坛医院神经内科,北京,100050
2. 中华医学会北京分会,北京,100005
基金项目:首都医学发展科研项目,中国博士后科学基金
摘    要:目的调查北京地区医院使用尿激酶(UK)和(或)重组组织型纤溶酶原激活物(rt-PA)静脉溶栓治疗的实施情况,为改进缺血性脑卒中的治疗提供依据。方法本调查为横断面调查研究,采用问卷形式调查北京地区医院脑卒中治疗相关的医疗资源方面的情况。结果北京地区被调查医院的总体结果:98.1%的医院有急诊室,92.6%的医院有24 h头颅CT,50%的医院有UK和(或)rt-PA静脉溶栓规程,7.4%的医院有卒中单元。有UK和(或)rt-PA静脉溶栓规程的医院与无此溶栓规程的医院比较差异有显著性意义的方面为:头颅CT、磁共振成像、磁共振血管造影、磁共振弥散加权成像、磁共振灌注加权成像、数字减影血管造影、神经科医生、神经外科医生、神经介入放射医生、动脉溶栓、颈动脉支架、颅内血管成形术、重症监护病房、神经重症监护病房、卒中单元、卒中治疗程序图或临床路径。结论北京地区医院应对其拥有的卒中相关医疗资源进行组织化,提高医院静脉溶栓能力,推广卒中小组、卒中单元、卒中治疗程序图或临床路径等治疗模式,以改进卒中治疗和改善卒中预后。

关 键 词:脑血管意外  尿纤溶酶原激活物  组织型纤溶酶原激活物  血栓溶解疗法  预后
文章编号:1009-0126(2005)06-0394-04
收稿时间:03 18 2005 12:00AM
修稿时间:2005年3月18日

Stroke treatment and prevention facilities survey in Beijing
WU Di,WANG Yi-long,GUO Xiang-ping, et al.Stroke treatment and prevention facilities survey in Beijing[J].Chinese Journal of Geriatric Cardiovascular and Cerebrovascular Diseases,2005,7(6):394-397.
Authors:WU Di  WANG Yi-long  GUO Xiang-ping  
Affiliation:Department of Neurology, Tiantan Hospital, Capital University of Medical Sciences, Beijing 100050, China
Abstract:Objective To investigate the situation of urokinase /recombinant tissue-type plasminogen activator(UK/rt-PA) therapy in hospitals located in Beijing area,thus providing some strategies for improving the prevention and treatment of stroke.Methods This cross-sectional investigation with a single-page survey was carried out to determine the situation medical sources related to stroke treatment in hospitals in Beijing.Results The general data about the investigated hospitals were: 98.1% of the surveyed facilities had emergency departments,and 92.6% had head CT service.Additionally,50% provided intravenous UK/rt-PA treatment,and 7.4% had stroke units.Comparisons between facilities providing UK/rt-PA and those without UK/rt-PA showed significant differences in the following aspects: head CT,MRI,MRA,DWI,PWI,and DSA;neurologist,neurosurgeon,and interventional neuroradiologist;intraarterial thrombolysis,carotid stenting,intracerebral angioplasty;ICU,NCU,stroke unit,and acute stroke care map/pathways.Conclusion Hospitals in Beijing should make the stroke-related medical sources organized,improve intravenous UK/rt-PA therapy,and advocate the applications of stroke team,stroke unit,stroke care map/pathway,which may improve stroke treatment and better stroke outcome.
Keywords:cerebrovascular accident  urinary plasminogen activator  tissue plasminogen activator  thrombolytic therapy  prognosis
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号